vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · IEX Real-Time Price · USD
27.96
+0.06 (0.22%)
At close: May 1, 2024, 12:00 AM
27.21
-0.75 (-2.68%)
After-hours: May 1, 2024, 5:23 PM EDT
vTv Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
68.02M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 2.02M | -1.99M | -49.61% |
Dec 31, 2021 | 4.01M | -2.41M | -37.56% |
Dec 31, 2020 | 6.41M | 3.65M | 132.05% |
Dec 31, 2019 | 2.76M | -9.67M | -77.77% |
Dec 31, 2018 | 12.43M | 12.14M | 4,172.85% |
Dec 31, 2017 | 291.00K | -343.00K | -54.10% |
Dec 31, 2016 | 634.00K | 115.00K | 22.16% |
Dec 31, 2015 | 519.00K | -1.03M | -66.49% |
Dec 31, 2014 | 1.55M | 573.00K | 58.71% |
Dec 31, 2013 | 976.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
MDxHealth | 70.19M |
Cryo-Cell International | 31.37M |
Carisma Therapeutics | 14.92M |
CollPlant Biotechnologies | 10.96M |
Asensus Surgical | 8.58M |
VTVT News
- 6 weeks ago - CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT - PRNewsWire
- 7 weeks ago - vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes - GlobeNewsWire
- 2 months ago - vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund - GlobeNewsWire
- 2 months ago - CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE - PRNewsWire
- 6 months ago - vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference - GlobeNewsWire